CEMTREX INC (CETX): Nasdaq/NYSE listing notice — Cemtrex regains compliance with Nasdaq minimum bid price; delisting hearing cancelled

CEMTREX INC

Received Nasdaq notice Feb 8, 2023 that bid price deficiency cured; company in full compliance with all listing standards.
Scheduled March 16, 2023 hearing before Nasdaq Hearings Panel has been cancelled.
Met minimum bid requirement on Feb 7, 2023 after 1-for-35 reverse stock split effective Jan 25, 2023.
Common stock continues trading on Nasdaq Capital Market under symbol CETX (new CUSIP 15130G 709).

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

CEMTREX INC received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 8, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that it has regained compliance with Listing Rule 5550(a)(2) and is in compliance with all applicable listing standards. The Company’s common stock will continue to be listed and traded on The Nasdaq Stock Market. The hearing scheduled for March 16, 2023 before the Hearings Panel has be cancelled.

View on SEC.gov

Browse all listing & compliance notices →

CEMTREX INC filing history →

Source: SEC EDGAR

accession 0001493152-23-004003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.